Home World USA Latin America Europe Asia Africa TV Shows Showbiz Travel Lifestyle Opinion Science Politics Health Sports Tech Entertainment Business
Health July 9, 2026

Celebrity Doctor Dr. Oz Links Obesity to Rise in Chronic Diseases, Recommends GLP-1 Therapies as Potential Health Boosters

Celebrity Doctor Dr. Oz Links Obesity to Rise in Chronic Diseases, Recommends GLP-1 Therapies as Potential Health Boosters

The use of GLP-1 weight-loss medications has gained significant traction in American healthcare, with the current administration expressing its support for their use in appropriate cases.

CMS Administrator Dr. Mehmet Oz recently voiced his endorsement of GLP-1 medications, such as Ozempic, during an interview at the Great American State Fair in Washington D.C. on July 6.

"I'm a fan of GLP-1 drugs when used correctly," Dr. Oz stated. "They help people who are overweight lose weight effectively. They're not a replacement for diet and exercise, but they can serve as a catalyst for adopting healthier habits."

The doctor noted that GLP-1 medications are particularly beneficial for individuals who may struggle with joint pain or internal dysfunction, making it more challenging to engage in physical activity.

Dr. Oz emphasized that certain GLP-1 drugs are already covered by Medicare for overweight individuals with conditions such as high blood pressure and diabetes.

He projected that the benefits of these medications will extend beyond the patients themselves, as they are likely to reduce healthcare costs for the federal taxpayer.

"We believe these medications will save money for the federal taxpayer because they will make individuals healthy enough to avoid consuming health services," Dr. Oz said.

The CMS Administrator also highlighted the significance of addressing chronic conditions, which account for approximately 70% of healthcare spending in the United States.

Obesity is the primary driver of these chronic conditions, making it a crucial area of focus for healthcare policymakers.

Dr. Oz announced the launch of the Medicare GLP-1 Bridge program, which will provide more seniors with access to GLP-1 medications at a reduced cost of $50 per month, subject to certain health criteria and prior authorization from a doctor.

The program aims to extend the benefits of GLP-1 medications to individuals who may not have previously qualified for them due to the absence of high blood pressure, diabetes, or other conditions.

While Dr. Oz acknowledged that there is no single solution to addressing weight-related health issues, he emphasized the importance of combining GLP-1 medications with foundational health practices such as proper nutrition, exercise, and stress management.

"There's no silver bullet when it comes to these medications," Dr. Oz said. "But combining them with healthy habits makes a lot of sense."

Share this article

UMVA MAG

UMVA Mag is your trusted source for breaking news, in-depth analysis, and compelling stories from around the world. Covering politics, business, technology, entertainment, sports, health, science, and more — we deliver journalism that matters.

Independent, Accurate, Unbiased
24/7 Breaking News Coverage
Trusted by Millions Worldwide